Georgina Buck
Contact information
Georgina Buck
BSc, MSc
Medical Statistician, CTSU
Georgina Buck gained a joint honours degree in Mathematics and Psychology at Nottingham University (1991-1994) and a Master's in Statistics with Applications in Medicine at Southampton University (1994-1995) before joining the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) at Oxford Population Health in 1995.
She worked on the Medical Research Council leukaemia trials until their transfer in 2013-2016 and started working on the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial in 2014.
Recent publications
Factors associated with adherence to allocated treatment in the ASCEND trial: a mail-based randomised trial of aspirin and of omega-3 fatty acid supplementation in people with diabetes.
Journal article
Madurasinghe VW. et al, (2026), Trials, 27
Active Monitoring for AtriaL FIbrillation (AMALFI): Rationale, protocol, and pilot for a pragmatic, randomized, controlled trial of remote screening for asymptomatic atrial fibrillation.
Journal article
Wijesurendra R. et al, (2025), Am Heart J, 290, 310 - 324
Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial.
Journal article
Wijesurendra R. et al, (2025), JAMA, 334, 1349 - 1357
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.
Journal article
Sammons E. et al, (2025), BMJ Open, 15
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial.
Journal article
Sammons EL. et al, (2024), BMC Ophthalmol, 24